Factors associated with emergency department (ED) attendance during last month of life
the ONA take:
According to a new study published in the Journal of Clinical Oncology, researchers from King's College London Cicely Saunders Institute in London, United Kingdom, have identified demographic and environmental factors associated with an increased risk of emergency department visits by patients with cancer during the final month of life.
For the study, researchers sought to investigate factors associated with emergency department attendance by patients with cancer during the last month of their lives. They analyzed data from five electronic databases and identified 30 studies that investigated emergency department attendance at the end of the lives of patients with cancer.
The studies included nearly 1.2 million patients from five countries and reported 13 environmental, five clinical, and three demographic factors in total.
Results showed an increased risk of emergency department attendance was associated with black race (OR = 1.45; 95% CI: 1.40 - 1.50), male gender (OR = 1.24; 95% CI: 1.19 - 1.29), having lung cancer (OR = 1.17; 95% CI: 1.10 - 1.23), and those of low socioeconomic status (OR = 1.15; 95% CI: 1.10 - 1.19).
Patients receiving palliative care were less likely to have an emergency department visit during the last month of life (OR = 0.43; 95% CI: 0.36 - 0.51).
Demographic and environmental factors associated with an increased risk of emergency department visits by patients with cancer.
Sign Up for Free e-newsletters
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Breast Implants Associated With Increased Risk of Breast Anaplastic Large-cell Lymphoma
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- OS Similar With Gemcitabine Plus S-1 vs Standard Therapy for Biliary Tract Cancer
- Feasibility and Outcomes of Modified Enhanced Recovery After Surgery for Nursing Management of Aged Patients Undergoing Esophagectomy
- Urine Drug Testing Policy Can Assist Opioid Treatment Decisions
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|